| Literature DB >> 28262212 |
Henry Zelada1, Dante Gamarra2, Hugo Arbañil2, Helard Manrique3.
Abstract
Type B insulin resistance (IR) is a rare autoimmune disease characterized by the presence of insulin receptor autoantibodies, resulting in a marked IR inducing hyperglycemia. Our first case is a 42-year-old female with a history of RA, SLE and Hashimoto-thyroiditis that presented with cachexia, acanthosis-nigricans, hirsutism, negative anti-insulin-ab and glucose level between 400 to 700 mg/dl, despite a total insulin dose of 1000 IU/day. She received pulses of cyclophosphamide along with prednisone. One year later the patient was off insulin and with HbA1c of 5.6%. The second case is a 42-year-old female patient that presented with polyuria, polydipsia, cachexia, acanthosis-nigricans, negative glutamic-acid-decarboxilase-ab and positive TPO-ab. She received IV infusion of regular insulin at a rate of 500 UI/d. Two years later she was off insulin with HbA1C of 5.6%. As summary, we reported a case of a disease remitted after receiving immunosuppressive therapy and a case of disease remitted spontaneously.Entities:
Keywords: Developing country; Immunosuppressive therapy; Insulin resistance; Latin America; Peru
Mesh:
Substances:
Year: 2016 PMID: 28262212 DOI: 10.1016/j.amjms.2016.07.001
Source DB: PubMed Journal: Am J Med Sci ISSN: 0002-9629 Impact factor: 2.378